Axel Bolte, MBA

Eight years of experience in private equity. Former investment manager at NMT, responsible for public biotech investments. Position in R&D management at Serono. Masters degrees from the University of St. Gallen and the ETH Zurich. Board member of PTC Therapeutics, Nabriva Therapeutics, Lux Biosciences and Ophthotech.